HPC Biosciences Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 4.9 million compared to INR 22.86 million a year ago. Revenue was INR 9.08 million compared to INR 23.71 million a year ago. Net loss was INR 4.94 million compared to net income of INR 11.7 million a year ago. Basic loss per share from continuing operations was INR 0.021 compared to basic earnings per share from continuing operations of INR 0.123 a year ago. Diluted loss per share from continuing operations was INR 0.021 compared to diluted earnings per share from continuing operations of INR 0.123 a year ago. Basic loss per share was INR 0.021 compared to basic earnings per share of INR 0.123 a year ago. Diluted loss per share was INR 0.021 compared to diluted earnings per share of INR 0.123 a year ago.